ZNF582 and nonpapillary renal cell carcinoma: To investigate the molecular mechanism of ZNF582-AS1 and identify its downstream targets in ccRCC, iTRAQ was performed to examine the expression changes at protein levels between the stable ZNF582-AS1-overexpressed OSRC2 cells and the control cells.